Celltrion gets first biosimilar approval

Celltrion Inc., a local biopharmaceutical company, announced Monday that it has won the Korea Food and Drug Administration (KFDA)’s approval to produce Korea’s first antibody biosimilar ‘Remsima’ after seven years of clinical trials and development.

Biosimilar products are officially approved subsequent versions of biopharmaceutical products made by a different firm after the rights to the ...